ClinicalTrials.Veeva

Menu

Fentanyl Background Infusion for Acute Postoperative Pain

A

Ajou University School of Medicine

Status

Completed

Conditions

Analgesia Disorder

Treatments

Other: D6-4-2
Other: D8-4-2
Other: FX2-2-2

Study type

Interventional

Funder types

Other

Identifiers

NCT01785823
AJIRB-DEV-DE1-11-288

Details and patient eligibility

About

We investigated the efficacy and the safety of the pharmacokinetic model-based patient-controlled analgesia (PCA) regimens of fentanyl for postoperative analgesia after total intravenous anesthesia (TIVA).

Full description

Infusions of fentanyl (2 ml/hr of diluent was equivalent with 0.5 μg/kg/hr of fentanyl) were maintained at the fixed-rate of 2 ml/hr until the postoperative 24 hr, or at the decremental rates of 6.0 ml/hr or 8.0 ml/hr during 1 hr, 4.0 ml/hr during 1~3 hr and 2.0 ml/hr during 3~24 hr, postoperatively.

Enrollment

99 patients

Sex

Female

Ages

20 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients who had undergone patient-controlled analgesia (PCA) after hysterectomy

Exclusion criteria

  • neurologic disorders
  • psychiatric disorders
  • renal or hepatic disorders

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

99 participants in 3 patient groups

FX2-2-2
Experimental group
Description:
Their background infusions of fentanyl diluent (2 ml/hr of diluent was equivalent with 0.5 μg/kg/hr of fentanyl) were maintained at the fixed-rate of 2 ml/hr until the postoperative 24 hr
Treatment:
Other: D8-4-2
Other: D6-4-2
D6-4-2
Active Comparator group
Description:
Their background infusions of fentanyl diluent (2 ml/hr of diluent was equivalent with 0.5 μg/kg/hr of fentanyl) were maintained at the decremental rates of 6.0 ml/hr (D6-4-2) during 1 hr, 4.0 ml/hr during 1\~3 hr and 2.0 ml/hr during 3\~24 hr,
Treatment:
Other: D8-4-2
Other: FX2-2-2
D8-4-2
Active Comparator group
Description:
Their background infusions of fentanyl diluent (2 ml/hr of diluent was equivalent with 0.5 μg/kg/hr of fentanyl) were maintained at at the decremental rates of 8.0 ml/hr (D8-4-2) during 1 hr, 4.0 ml/hr during 1\~3 hr and 2.0 ml/hr during 3\~24 hr,
Treatment:
Other: FX2-2-2
Other: D6-4-2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems